current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: IDP00005 internalin, putative BA_0552 [Bacillus anthracis str. Ames], from CSGID

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070
# Score Template Links and tools%idFirst MLVAATLSLPFAVYATPILAATAATENMAVQSPKKHVFDAVIKAYKDNSDEESYATVYIKDPKLTIENGKRIITATLKDSDFFDYLKVEDSKEPGVFHDVKVLSEDKRKHGTKVIQFEVGELGKRYNMQMHILIPTLGYDKEFKIQFEVNMRTFVESDIEEDEEEQIEDTQNIIRDKRLQQAINKNVLNRKDVNEPIFEEDLKEIKELNIYAGQGIESLKGLEYMENLERITIQGSDVRNIAPISQLKRLKVVDLSFNKIENVEPLVNLEKLDILELQNNRIADVTPLSQLKKVRTINLSGNKISDIKPLYNVSSLRKLYVSNNKITDFTGIEQLNKLGTLGVGSNGLVNIEPISQMSGIVELNLEKNDIKDITSLSKLTGLQSLNLEENYVSDVSSLSNLINLYELKLATNEIRDIRPIQELGKRIKIDAQRQKVFLDEAYMNEEVKIPVYDVNGTALQNIEWKSEGGSITNGVIKWNSLGEKMYEFKMDAGESKIRFQGRVIQNIVEKREESSNVIQDMKLRQYMNKHNFERKNVNTPITKEDLLTVKALKITDGKKEGITDFSGLEFMTNVEELTLQNVNMKNAEFISSLRNLKSVDLSYNQIEDIKPLHSLEDLEKLNVSDNGIKNVPELFKMQKLKTLDLSNNKLDNAALDGIHQLENLDALLVNNNEINNLDEISKVSKLNKLEMMSNKVRDISPLASLKNLQWLNLSDNKIQDISTLSSMLDLLSLKLAGNEIRDVRPVIQLAQWITVDIKNQKIVLEDGQMNQEIQIPIYDLEGEIFEDIELKSTDGIVTDRGTVVWKTPGAKIYSFSLNGNYHGLSLLFSGTVTQNIVAKEEPKEPVEEVEGSKEEPIKEAEGSKEEPKEPAKEVEGSKEEPKEPAKEVEGSKEEVKEPAKEVEGPKEEVKEPTKEVEGPKEEVKEPTKEVEGPKEEVKEPMKEVEGSKEEVKGPTKEAEGSKEEVKEPTTEVEGSKEVKEPGKEVEGSKDAINQSAVAQETNVNNQVGKEKVVENQNMKENKPAVTKQEESKKSLGATGGQENTSTLLSGLALVLSALSMFVFRKRLFKKLast
1 -82.4003w3g_A mol:protein length:811 Toll-like receptor 8  ali model follow..  15  2.........................................................................................SPWEENFSRSPCDEKKQNDSVIAECSNRRLQEVPQTV--GKYVTELDLSDNFITHIESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNI-------------TDGAFLNLKNLRELLLEDNQLPQIPSGL--PESLTELSLIQNNIYNITKISRLINLKNLYLAWNCYFNKGVFETLTNLELLSLSFNSLSHVPP-KLPSSLRKLFLSNTQIKYISEFKGLINLTLLDLSGNCPRCFNAFQNLTQLRYLNLSSTSLRKINAFKNMPHLKVLDLEFNYLVG-AFLTMLPRLEILDLSFNYIKGSRNFSKLLSLRALHLRGYVFQELRELMQLPNLSTINLGINFIKQIFKLFQNFSNLEIIYLSENRISPLVKRQSYANSSSFQRHIRKRRSTDF------------------------------------------EFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPFENLPDIACLNLSANSNAQVTEFSAIPHVKYLDLTNNRLDFDNALTELSDLEVLDLSYNSHYHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILSIFKGLKNLTRLDLSLNRLKHIPN-NLPASLTELHINDNMLKFFTLLQQFPRLELLDLRGNKLLFLTDSDFTSSLRTLLLSHNRISHLSGFLSEVSSLKHLDLSSNLLKTINKSAL--------------------ETKTTTKLSMLELHGNPFETCDIGDFRRWMDEHLNVKIPRLVDVIASPGDQRGKSIVSLELTTCVSDVTEFL......................................................................................................................................................................................... 808
2 -81.2001o6s_A mol:protein length:466 INTERNALIN A  ali model follow..  23  2...........................................................................................................................................................................................................PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG-NQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNG------------------------------------------------------------------------------------------------------------------------------NQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPNYKANVSIPNTVKNVTGALIAATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA................................................................................................................................................................................................................................................................................... 466
3 -80.3003wpf_A mol:protein length:803 Toll-like receptor 9  ali model follow..  15  13......................................................................................................PCELKPHGLVDCNWLFLKSVPSAAASCSNITRLSLISNRIHHLSDFVHLSNLRQLNLKWNCPPT----------------LSPLHFSCHMTIEPRTFLAMRTLEELNLSYNGITTVPR---LPSSLVNLSLSHTNILVLDALAGLYSLRVLFMDGNCYYKNGALLGLSQLTHLSLKYNNLTKVPR-QLPPSLEYLLVSYNLIVKLEDLAQLTSLRVLDVGGNCRRC-ETFHHLSHLEGLVLKDSSLHTLNSFQGLVQLSVLDLSENFLYE-NAFQNLTRLRKLNLSFNYRKKVSSFKNLVSLQELNMNGIFFRLLNKLADLPKLHTLHLQMNFINQALSIFGTFRALRFVDLSDNRISGPSTLSEATPEEADDAEQEELLSADPHPAPLSTPASKNFMNFKFTMDLSRNNLVTIKPEMFVQLSRLQCLSLSHNSIAQAVNGSQFLPLTNLQVLDLSHNKLDLYHWFSELPQLQALDLSYNSQPFSSFVTHLSMLQSLSLAHNDIHTRVS--NSNSVRFLDFSGNGMGRMWDFQGLSGLLKLDLSQNNLHILRPQNLDNLKSLKLLSLRDNYLSFFTSLSFLPNLEVLDLAGNQLKALTQLPNGTLLQKLDVSSNSIVSVVPFALAVELKEVNLSHNILKTVDR-PIVMQLTVLDVRSNPLHCAGAAFVDLLLEVQTKVPGNGVKCGSPGQLQGRSIFAQDLRLCL....................................................................................................................................................................................................................................................................... 790
4 -78.8004z0c_A mol:protein length:709 Toll-like receptor 13  ali model follow..  13  2.......GFNKCTQYEFDIHHVLCIRKKITNLTEAISDIPRYTTHLNLTH-------------------NEIQVLPPWSFTNLSALVDLRLEWNSIWKIEGAFRGLENLTLLNLVENKIQSVNNSFEGLSSLKTLLLSHNQITHIHKFTPLIKLKYLSLSRNNISDFSGI-------------------------LEAVQHLPCLERLDLTNNSIMYLDHSPRSLVSLTHLSFEGNKLRELNSALSLPNLTNLSASRNGNKVIQNLKTLPQLKSLNLSGTVIKLENSAKHLQNLRAMDLSNWELRHGHLLGNLPKLETLVFQKNVTNAEGILAKCTRLLFLDLGQNSDLIYSEFNALPSLQKLNLNKCQLSFINNWSSLQNLTSLDLSHNKFKSFPDFSPLKHLEFLSLSRNPITELNNFSGLFALKELNLAACWIVTIRYSFTQFPNLEVLDLGDNNIRTLNH-------------------------------------------------------------------------------GTFRPLKKLQSLILSHNCLKILEPFSGLTNLRSLDLMYNSLSYFHEFSGLEKLLILKLGFNKITYETTFIKLKSLKQLNLEGQRHGPSNFFQGLGSLQELLLGKNPSVFLDHHQFDPLINLTKLDISGTKDGDRSLFQNLKRLKILRLENNNLESLVPFSSLQSLQVFSLRFNNLKVISHLKNLKSLMFFDVYGNKLQCTCDWFKNWSMNTEEVHIPFLRSYCQQPGSQSLLIDFDDA................................................................................................................................................................................................................................................................................................. 707
5 -76.3003wpb_A mol:protein length:802 Toll-like receptor 9  ali model follow..  16  14.......................................................................................................CELQPHGLVNCNWLFLKSVPSAAAPRDNVTSLSLLSNRIHHLSDFAQLSNLQKLNLKWNCPPAGLSPMHFPCHMTIE---------------PNTFLAVPTLEELNLSYNGITTVPA---LPSSLVSLILSRTNILQLDPLTGLHALRFLYMDGNCYYK-GALLGLGNLTHLSLKYNNLTTVPR-SLPPSLEYLLLSYNHIVTLAPLANLTALRVLDVGGNCRRC-DTFSHLSRLEGLVLKDSSLYQLNPFRGLGNLTVLDLSENFLYDCKAFQGLAQLRRLNLSFNYHKKVPSFGSLLSLQELDMHGIFFRSLSPLARLPMLQRLYLQMNFINQALGIFKDFPGLRYIDLSDNRISGAVETGEVDGGKKVWLTSRDLTPGPLDTPSSEDFMP-SCKNLSFTLDLSRNNLVTVQPEMFAQLSRLQCLRLSHNSISQAVNGSQFVPLTSLQVLDLSHNKLDLYHGFTELPRLEALDLSYNSQPNLSFVAQLPTLRYLSLAHNGIHSRVSQQCSTSLWALDFSGNSLSQMWAFQGLRSLIRLDLSQNRLHTLLPCTLGNLKSLQLLRLRNNYLAFFSSLTLLPNLETLDLAGNQLKALSNLPSGTQLQRLDVSRNSIIFVVPFALATRLRELNLSANALRTVEPFGFLGSLEVLDVSANPLH................................................................................................................................................................................................................................................................................................................... 742
6 -76.1003wpe_A mol:protein length:801 Toll-like receptor 9  ali model follow..  15  14.......................................................................................................CELQPHGQVDCNWLFLKSVPSAGAPRANVTSLSLISNRIHHLSDFVHLSNLRVLNLKWNCPPAGLSPMHFPCRMTIE---------------PNTFLAVPTLEELNLSYNGITTVPA---LPSSLVSLSLSHTSILVLGPFTGLHALRFLYMDGNCYYMNGALLGLGNLTHLSLKYNNLTEVPR-RLPPSLDTLLLSYNHIVTLAPLANLTALRVLDVGGNCRRC-DTFSHLSRLEGLVLKDSSLYKLEKFRGLGRLQVLDLSENFLYDYTIFNDLTQLRRLNLSFNYHKKVSSFGSLVSLEKLDMHGIFFRSLTSLTRLPKLQSLHLQLNFINQALSIFGAFPSLLFVDLSDNRISGAATAALGEVDSRVEVWRLPRGLAPGPLDAVSSKDFMPSCNLNFTLDLSRNNLVTIQQEMFTRLSRLQCLRLSHNSISQAVNGSQFVPLTSLRVLDLSHNKLDLYHGFTELPQLEALDLSYNSQPNLSFVAQLPSLRYLSLAHNGIHSRVS--SSASLRALDFSGNSLSQMWAFKGLRNLVQLDLSENHLHTLLPRHLDNLKSLRQLRLRDNNLAFFSSLTVLPRLEALDLAGNQLKALSNLPPGIRLQKLDVSSNSIGFVIPFVRATRLIELNLSANALKTVDPFGSLGTLKILDVSANPLHCAGAAFVDFLLERQEAVPSRRVTCGSPGQLQGRSIFTQDLRLCL....................................................................................................................................................................................................................................................................... 788
7 -73.5004fmz_A mol:protein length:347 Internalin  ali model follow..  24  2.....................................................................................................................................................................................................................................................................................................AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIE-----------------------------------------------------------DISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIKK.................................................................................................................................................................................................................................................................................................................................................................................... 347
8 -71.9003cig_A mol:protein length:697 Toll-like receptor 3  ali model follow..  16  3.........................................................................................................TVRYNVADCSHLKLTHIPDDL--PSNITVLNLTHNQLRRLPNFTRYSQLAILDAGFNSISKLEP---------------------------ELCQILPLLKVLNLQHNELSQISDQFVFCTNLTELDLMSNSIHKIKSFKNQKNLIKLDLSHNGLSSTKLGVQLENLQELLLAKNKILALREFLGNSSLRKLDLSSNPLKEFSPFQTIGKLFALLLNNAQLNPHLT--SNTSIQNLSLANNQLLATSE--KWTNLTQLDLSYNNLHDVGNFSYLPSLRYLSLEYNNIQRLSPFYGLSNLRYLSLKRAFTKQSVSLASHPNID------------DFSFQWLKYLEYLNMDDNNIPSTKSNTFLVSLKYLSLSKTFTSLQTLTNETFVSLAH-----------------------------------------------------SPLLTLNLTKNHISKIANFSWLGQLRILDLGLNEIEQKQEWRGLRNIFEIYLSYNKYLQLSTFALVPSLQRLMLRRVALKNVDPFRPLRNLTILDLSNNNIANINEDLLEGLENLEILDFQHNNLARLWKLKGLSHLHILNLESNGLDEIPVFKNLFELKSINLGLNNLNKLEPFDDQTSLRSLNLQKNLITSVEK-PPFQNLNSLDMRFNPFDCTCESISWF--VNWINQTHTNISELSTHYL..................................................................................................................................................................................................................................................................................... 650
9 -71.6003ulu_A mol:protein length:694 Toll-like receptor 3  ali model follow..  15  2..............................................................................................DLGSASSTTKCTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAFTRYSQLTSLDVGFNTISKLEP---------------------------ELCQKLPMLKVLNLQHNELSQLSDKFAFCTNLTELHLMSNSIQKIKNFVKQKNLITLDLSHNGLSSTKTQVQLENLQELLLSNNKIQALKS--ANSSLKKLELSSNQIKEFSPFHAIGRLFGLFLNNVQLGPSLTELANTSIRNLSLSNSQLSTTSN--KWTNLTMLDLSYNNLNVVGNFAWLPQLEYFFLEYNNIQHLFSLHGLFNVRYLNLKRSFTKQSISLASLPKID------------DFSFQWLKCLEHLNMEDNDIPGIKSNMFLINLKYLSLSNSFTSLRTLTNETFVSL-----------------------------------------------------AHSPLHILNLTKNKISKIESFSWLGHLEVLDLGLNEIGQEQEWRGLENIFEIYLSYNKYLQLTRFALVPSLQRLMLRRVALKNVDSFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKLKGLSHLHILNLESNGFDEIPVFKDLFELKIIDLGLNNLNTLPAFNNQVSLKSLNLQKNLITSVEK-PAFRNLTELDMRFNPFDCTCESIAWF--VNWINETHTNIPELS......................................................................................................................................................................................................................................................................................... 656
10 -69.7004lxr_A mol:protein length:783 Protein toll  ali model follow..  13  32...................................................................NAENPTFRLTIQPKDYVQIMCNLTDTTDYQQLPKKLRDRVQMRRCMLPGHTPIASLDYLGIVSPTTLIFESDNLGMNITRLDRLHGLKRFRFTTRRLTHIPA---------------------------NLLTDMRNLSHLELRANIEEMPSHLFDDLENLESIEFGSNKLRQMPRFGKMPKLKQLNLWSNQLHNLTKFEGATSVLGIDIHDNGIEQLPHFAHLTNVTDINLSANLFRSLPQFDHNKHLNEVRLMNNRVPPSRLFANQPELQILRLR-AELQSLPGFEHSTQITNISLGDNLLKTLPALEHQVNLLSLDLSNNRLTHLPDFAHTTNLTDLRLEDNLLTGISGFSNLGNLVTLVMSRNRLRTIDSRFVSTNGLRHLHLDHNDIDLQQPLL--------------------------------------------------------------------DIMLQTQINSPFGYMHGLLTLNLRNNSIIFVYNKNTMLQLRELDLSYNNISSLGY-FLSQNRLHVNMTHNKIRRIAGEGYNNNLVHVDLNDNPLVQYSRQFKLRTDRLVCSQPNVLEGTPVRQIEPQTLICPLDFSDDPRERKCPVRTYDKALVINCHSGNLTHVPRLHKNMQLMELHLENNTLLRLPSTPGYESVTSLHLAGNNLTSIDVDQLPTNLTHLDISWNHLQMLNATLNRTMKWRSVKLSGNPWM............................................................................................................................................................................................................................................................................................ 727
11 -69.4004g8a_A mol:protein length:635 Toll-like receptor 4  ali model follow..  15  2.................................................................................................................................................SPWDYKDDDDKLAAANSSIPESWE---------------------------PCVEVVPNITYQCMELN-FYKIPDNLP--FSTKNLDLSFNPLRHLGSFFSFPELQVLDLSRCEIQTIEDYQSLSHLSTLILTGNPIQSLALFSGLSSLQKLVAVETNLASLENIGHLKTLKELNVAHNLIQSFEYFSNLTNLEHLDLSSNKIQSITDLRVLHQMPSLDLSLNPMNFIQPFKEIRLHKLTLRNNFDSLNVTCIQGLAGLEVHRLVLGEFRNEGNLEGLCNLTIEEFRLAYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------------------------------------------------------------LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGSDFGTISLKYLDLSFNGVITMSSFLGLEQLEHLDFQHSNLKQMSEFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENDIFTELRNLTFLDLSQCQLEQLSPFNSLSSLQVLNMSHNNFFSLDTYKCLNSLQVLDYSLNHIMTSKKLQHFSSLAFLNLTQNDFAEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT.......................................................................................................................................................................................................................................................................... 624
12 -69.4002a0z_A mol:protein length:705 Toll-like receptor 3  ali model follow..  16  3....................................................................................................STTKCTVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAFTRYSQLTSLDVGFNTISKLEP---------------------------ELCQKLPMLKVLNLQHNELSQLSDKFAFCTNLTELHLMSNSIQKIKNFVKQKNLITLDLSHNGLSSTKTQVQLENLQELLLSNNKIQALKS--ANSSLKKLELSSNQIKEFSPFHAIGRLFGLFLNNVQLGPSLTELANTSIRNLSLSNSQLSTTSN--KWTNLTMLDLSYNNLNVVGNFAWLPQLEYFFLEYNNIQHLFSLHGLFNVRYLNLKRSFTKQSISLASLPKID------------DFSFQWLKCLEHLNMEDNDIPGIKSFTGLINLKYLSLSNSFTSLRTLTNETFVSL-----------------------------------------------------AHSPLHILNLTKNKISKIESFSWLGHLEVLDLGLNEIGQEQEWRGLENIFEIYLSYNKYLQLTRFALVPSLQRLMLRRVALKNVDSFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKLKGLSHLHILNLESNGFDEIPVFKDLFELKIIDLGLNNLNTLPAFNNQVSLKSLNLQKNLITSVEK-PAFRNLTELDMRFNPFDCTCESIAWF--VNWINETHTNIPEL.......................................................................................................................................................................................................................................................................................... 650
13 -69.2005il7_A mol:protein length:1102 Rab family protein  ali model follow..  22  3.........................................................................................................................................DLDVIRQIEQEMQLEPVDKLKWYSKGYK------------------------------LDKDQRVTAIGLYDCGSDTLDRIIQPLESLKSLSELSLSSNQITDISPLASLNSLSMLWLDRNQITDIAPLASLNSLSMLWLFGNKISDIAPLESLKSLTELQLSSNQITDIAPLASLKSLTELSLSGNNISDIAPLESLKSLTELSLSSNQITDIAPLASLKSLTELSLSSNQISDIAPLESLKSLTELQLSRNQISDIAPLESLKSLTELQLSSNQITDIAPLASLKSLTELQLSRNQISDIA-PLESLNSLSKLWLNGNQITDI---------------------------------------------------------------------------------APLASLNSLTELELSSNQITDIAPLASLKSLSTLWLSSNQISDIAPLASLESLSELSLSSNQISDISPLASLNSLTGFDVRRNPIKRLPEWNDFSSSGFITFFDNPLESPPPEIVKQGKEAVRQYFQSIEEARSGEALVHLQEIKVHLIGDQLIGETFDPKESQTHGLNVVTKQAPNIKGLENDDELKECLFHFWDFGGQEIMHASHQF----MTRSSVYML................................................................................................................................................................................................................................................................................................................. 538
14 -68.7003a79_B mol:protein length:562 Toll-like receptor 6, Variable lymphocyte rec  ali model follow..  14  9.............................................................................................................................................................................................................................VGSFHFVCALALIVGSMTPFS----NELESMVDYSNRNLTHVPK----PRTKALSLSQNSISELRMISFLSELRVLRLSHNRIRSLDFFLFNQDLEYLDVSHNRLQNI-SCCPMASLRHLDLSFNDFDVLKEFGNLTKLTFLGLSAAKFRQLDPVAHLHSCILLDLVSYHIKGGEESLQIPNTTVLHLVFHPNSLFSVQVQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCQFFWPRPVEYLNIYNLTITERI----------------------------------------------------DREEFTYSETALKSLMIEHVKNQVFLFSKEYSVFAEMNIKMLSISDTPFIHMPPSPSSFTFLNFTQNVFTDSVFCSTLKRLQTLILQRNGLKNFFKTKNMSSLETLDVSLNSLNSHAYDRCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKVTHLQALQELNVASNQLKSVPDFDRLTSLQYIWLHDNPWDGIRYLSEWINKHSGVVRNSAGSVAPDSA-SGSGKPVRSIICPTLV............................................................................................................................................................................................................................................................................................ 560
15 -68.4003rg1_A mol:protein length:612 CD180 molecule  ali model follow..  14  4...................................................................................................................................................................................................DPKCTEKEGNRTYNCENLGLREIPDTL--PNTTEVLEFSFNFLPTIQNFSRLINLIFLDLTRCQINWVHEFQSHHQLNTIVLTGNPLIFMAELTGPKFLKHLFLTQTGISNLEPVHNLENLESLHLGSNHISSINENFPTQNLKVLDFQNNAIHYISRTNSLEQATSLNFNGNDIKGIEPNSTLQSLWLGTFEDTDDQYLTS--CDMSVESINLQKHRFSDLSSFRCFTRVQELDLTAAHLNGLPSGIEGMNSLKKLVLNANSFDQLCQIN------------------------------------------------------AASFPSLRDLYIKGNMRKLDLGTRCLEKLENLQKLDLSHSDIEASDQLKNLRHLQYLNLSYNEPLGLEDFKECPQLELLDVAFTHLHVKAPFQNLHLLRVLNLSHCLLDTSNQLAGLQDLRHLNLQGNSFQDGSINLLQMVGSLEILILSSCNLLSIDQFHGLRNVNHLDLSHNSLTGDSMLSHLKGLY-LNMASNNIRIIPPLPALSQQSIINLSHNPLD---TCSNIHFITWYKENLHKLEDSEETCANPPSLRGVKLSDVKLHCGTHMLVP.................................................................................................................................................................................................................................................................................... 611
16 -68.2005ijb_A mol:protein length:594 Toll-like receptor 4, Variable lymphocyte rec  ali model follow..  16  1....................................................................................................................................................................................................NPCIEVVPNITYQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSFSNFSELQWLDLSRCEIETIEDWHGLHHLSNLILTGNPIQSFSPFSGLTSLENLVAVETKLASLESIGQLITLKKLNVAHNFIHSCKYFSNLTNLVHVDLSYNYIQTITV-ENPQVNLSLDMSLNPIDFIQDFQGIKLHELTLRGNFNSSNIMKLQNLAGLHVHRLILGEFKDERNLEIFETIDEFRLTYTNDFSDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF------------------------------------------------------------PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGSDLGTNSLRHLDLSFNGAIIMSAFMGLEELQHLDFQHSTLKRVTEFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLFANTTNLTFLDLSKCQLEQISWFDTLHRLQLLNMSHNNLLFLDSYNQLYSLKELALDTNQLKSVPDFDRLTSLQKIWLHTNPWDCSCPRIDYLSR........................................................................................................................................................................................................................................................................................................ 565
17 -67.7002z63_A mol:protein length:570 Toll-like receptor 4, Variable lymphocyte rec  ali model follow..  16  1...........................................................................................................................................................................................................................EPCVEVVPNITYQCMELNFYKIPD----FSTKNLDLSFNPLRHLGSFFSFPELQVLDLSRCEIQTIEDYQSLSHLSTLILTGNPIQSLALFSGLSSLQKLVAVETNLASLENIGHLKTLKELNVAHNLIQSFKYFSNLTNLEHLDLSSNKIQSIYCLRVLHQMPLLNLS------------------LDLSLNPMNFIQPAFKEIRLHKLTLRNNFDSLMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN-----------------------------------------------TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT-LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGSDFGTTSLKYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFLSLRNLIYLDISHTHTRVAFNFNGLSSLEVLKMAGNSFQENDIFTELRNLTFLDLSQCQLEQLSPFNSLSSLQVLNMASNQLKSVPDGFDRLTSLQKIWLHTNPWD............................................................................................................................................................................................................................................................................................ 531
18 -67.6003t6q_A mol:protein length:606 CD180 antigen  ali model follow..  16  1...............................................................................................................................................................................................TTSSDQKCIEKEVNKTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNFSRLINLTFLDLTRCQIYWIHEFQSQHRLDTLVLTANPLIFMAELSGPKALKHLFFIQTGISSIDPLHNQKTLESLYLGSNHISSIKKGFPTEKLKVLDFQNNAIHYLSKMSSLQQATSLNLNGNDIAGIEPNSTIQSLWLGTFEDMDDEDISPFEGLCSVESINLQKHYFFNISSFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQIS------------------------------------------------------ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDQLRNLSHLQSLNLSYNEPLSLKTFKECPQLELLDLAFTRLKVKDAFQNLHLLKVLNLSHSLLDISSEFDGLPALQHLNLQGNHFPKGKTNSLQTLGRLEILVLSFCDLSSIDQFTSLKMMNHVDLSHNRLTSSSALSHLKGIY-LNLASNHISIILPLPILSQQRTINLRQNPLD---TCSNIYFLEWYKENMQKLEDTEDTLENPPLLRGVRLSDVTLS............................................................................................................................................................................................................................................................................................ 604
19 -67.2002z7x_B mol:protein length:520 Toll-like receptor 1, Variable lymphocyte rec  ali model follow..  13  1..................................................................................................................................................................................................................................SEFLVDRSKNGLIHVPK-DLSQKTTILNISQNYISELWTILSLSKLRILIISHNRIQYLDIFKFNQELEYLDLSHNKLVKI-SCHPTVNLKHLDLSFNAFDALPEFGNMSQLKFLGLSTTHLEKSSVIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN-KEFHFILDVSVKTVANLELSNI-------KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV----------------------------------------------------------------------------WHTTVWYFSISNVKLQGQLDFRSLKALSIHQVVSDVFGFPQSYEIFSNMNIKNFTVSGTRMVHMPSKISPFLHLDFSNNLLTDTENCGHLTELETLILQMNQLKELSAEMTTQMKSLQQLDISQNSVSYDEKCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKVVKLEALQELNVASNQLKSVPDFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGS............................................................................................................................................................................................................................................................................................ 504
20 -66.5003b2d_A mol:protein length:603 CD180 antigen  ali model follow..  15  4.....................................................................................................................................................................................................MCIEKEANKTYNCENLGLSEIPDTL--PNTTEFLEFSFNFLPTIHNFSRLMNLTFLDLTRCQINWIHEFQSHHQLSTLVLTGNPLIFMAELNGPKSLKHLFLIQTGISNLEPVHNLENLESLYLGSNHISSIKFDFPARNLKVLDFQNNAIHYISRMRSLEQAINLSLNFNGNN--LGAFDSTIFQSLNFGGTPNLSVNGLQNSTSVESLNLQEHRFSDISSFQCFTQLQELDLTATHLKGLPSGMKGLNLLKKLVLSVNHFDQLCQIS------------------------------------------------------AANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDQLKNLSHLQTLNLSHNEPLGLQSFKECPQLELLDLAFTRLHINAPFQNLHFLQVLNLTYCFLDTSNQLAGLPVLRHLNLKGNHFQDGKTNLLQTVGSLEVLILSSCGLLSIDQFHSLGKMSHVDLSHNSLTCDSILSHLKGIY-LNLAANSINIISPLPILSQQSTINLSHNPLD---TCSNIHFLTWYKENLHKLEGSETTCANPPSLRGVKLSDVKLS............................................................................................................................................................................................................................................................................................ 601
21 -66.4002z7x_A mol:protein length:549 Toll-like receptor 2, Variable lymphocyte rec  ali model follow..  15  3...............................................................................................................................................................................................................................SCDRNGICKGSSGSLNSIPS-GLTEAVKSLDLSNNRITYISNLQRCVNLQALVLTSNGINTIEEFSSLGSLEHLDLSYNYLSNLSSFKPLSSLTFLNLLGNPYKTLGEFSHLTKLQILRVGNMDTFTKKDFAGLTFLEELEIDASDLQSYEPLKSIQNVSHLILHMKQHILLLEVDVTSSVECLELRDTDLDTFHSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDD-----------CTLNGVGNFRASDNDR---------------------------------------------------------VIDPGKVETLTIRRLHIPRFYLFYDLSYSLTERVKRITVENSKVFLVPCSQHLKSLEYLDLSENLMVEEY-EDAWPSLQTLILRQNHLASLEKLLTLKNLTNIDISKNSFHSMP-ETCQWPEKMKYLNLSSTRIHSVTG-CIPKTLEILDVSNNNLNLFS--LNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNQLKSVPDFDRLTSLQKIWLHTNPWD................................................................................................................................................................................................................................................................................................................... 510
22 -66.2004r6g_A mol:protein length:464 leucine rich repeats DLRR_K  ali model follow..  17  1............................................................................................................................................................................................................................................................................................................TITVSTPIKFPDDAFAETIKANLKKKSVTDAQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQFEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNNLANLNDRFEGLTNLTTLNLSNNNLARLW-----------------------------------------------------------------------KHANPGGPIYFLKGLTNLTTLNLSNNGFDELPKFKDLTSLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTSLTTLNLSNNQLTSLPKGVLERLTNLKTLNLSNNQITKEELLKQAASLHELHLSNNNIGEEGALHPGSTLETLDLSNCNLTKERALKQATTLHELHLSNNNIGEEGALHPGSTLETLDLSNCNLTKIARALKQATSLHELHLSNNNIGS........................................................................................................................................................................................................................................................................................... 464
23 -66.0003vq1_A mol:protein length:606 Toll-like receptor 4  ali model follow..  16  10.........................................................................................................................................................................................................VVPNITYQCMDQKLSKVPDDI--PSSTKNIDLSFNPLKILKSFSNFSELQWLDLSRCEIETIEDWHGLHHLSNLILTGNPIQSFSPFSGLTSLENLVAVETKLASLESIGQLITLKKLNVAHNFIHSCKYFSNLTNLVHVDLSYNYIQTITVLQFLRENPSLDMSLNPIDFIQDFQGIKLHELTLRGNFNSSNIMKLQNLAGLHVHRLILGEFKDERNLEIFETIDEFRLTYTNDFSDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF------------------------------------------------------------PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSGTNSLRHLDLSFNGAIIMSAFMGLEELQHLDFQHSTLKRVTEFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNNVFANTTNLTFLDLSKCQLEQISWFDTLHRLQLLNMSHNNLLFLDSYNQLYSLSTLDCSFNRIETSKGQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQM.......................................................................................................................................................................................................................................................................................... 583
24 -63.6003a79_A mol:protein length:580 Toll-like receptor 2, Variable lymphocyte rec  ali model follow..  16  29...............................................................................................................................................................................................................................SCDASGVCDGRSRSFTSIPS---TAAMKSLDLSFNKITYIGHLRACANLQVLILKSSRINTIEGFYSLGSLEHLDLSDNHLSSLSSFGPLSSLKYLNLMGNPYQTLGVFPNLTNLQTLRIGNVETFSEIDFAGLTSLNELEIKALSLRNYQSLKSIRDIHHLTLHLSESAFLLEADILSSVRYLELRDTNLARFQFSPAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV-----------------------------------------------------------------------ETVTIRRLHIPQFYLFYDLSYSLLEKVKRITVENSKVFLVPFSQHLKSLEFLDLSENLMVEEACKGAWPSLQTLVLSQNHLRSMQKLLTLKNLTSLDISRNTFHPMP-DSCQWPEKMRFLNLSSTGIRVVKT-CIPQTLEVLDVSNNNLDSFS--LFLPRLQELYISRNKLKTLPDASLFPVLLVMKIASNQLKSVPDFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK................................................................................................................................................................................................................................................................................................ 555
25 -63.6004mn8_A mol:protein length:782 LRR receptor-like serine/threonine-protein ki  ali model follow..  14  58..KQLEGVLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYL-------------------NYFSGSIPSGIWELKNIFYLDLRNNLLSGVPEEICKTSSLVLIGFDYNNLGKIPECLGDLVHLQMFVAAGNHLTG-VSIGTLANLTDLDLSGNQLTG---------------------------KIPRDFGNLLNLQSLVLTENLLEGDIPEIGNCSSLVQLELYDNQLTG-AELGNLVQLQALRIYKNKLTS-SSLFRLTQLTHLGLSENHLVGSEEIGFLESLEVLTLHSNNFTGPQSITNLRNLTVLTVGFNNISGELPLGLLTNLRNLSAHDNLLTG-SSISNCTGLKLLDLSHNQMTGIPRGFGRMNLTFISIGRNHFTGPDDIFNCSNLETLSVADNNLTGTLKIGKLQKLRILQVSYNSLTPIPREIGNLKDLNILYLHSNGFTGRIP-------------------------------------------------------------------------------REMSNLTLLQGLRMYSNDLEG-EEMFDMKLLSVLDLSNNKFSG-ALFSKLESLTYLSLQGNKFNGSIPLKSLSLLNTFDISDNLLTGTIPGELLASLKYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSG-RSLQACKNVFTLDFSQNNLSG-DEVFQGMDMIILNLSRNSFSG-QSFGNMTHLVSLDLSSNNLTGEIPLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNT.............................................................................................................................................................................................................................................................................................. 756
26 -61.9004ecn_A mol:protein length:876 Leucine-rich repeat protein  ali model follow..  10  137LSKEGISTRAAGEYLFSNIRYVDVTVMNSFNRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVW-LPAGTYQVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETA---------------EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDIGQLTELKVLSFGTHSETVSGRFGDEELTPDMSEERKHRIRMHKKMFLDYDQRLNLSDLLQDAINRNPEMKPITQIGNLTNRITFISAIQRLTKLQIIYFANSPFTYDNSWSNLKDLTDVELYNPNMTQLPDLYDLPELQSLNIACNRGISAAQEDTGPKIQIFYMGYNNLEEFPALQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCATDQVEGLGFSHNKLKYIPNAKSVYVMGSVDFSYNKIGSEG----------------------------------------------------RNISCSMDDYKGINASTVTLSYNEIQKFPTFATGSPISTIILSNNLMTSIPEYKNTYLLTTIDLRFNKLTSLSDATTLPYLSNMDVSYNCFSSFPQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE-KLTPQLYILDIADNPNISITSVCPYIEAGMYVLLYDKTQD------IRGCDALGIER............................................................................................................................................................................................................................................................................................................................................. 876
27 -60.3003oja_A mol:protein length:487 Leucine-rich Immune Molecule 1  ali model follow..  14  4...........................................................................................................................................................................................................................EIKQNGNRYKIEKVTDSSLKQALARQSAWNVKELDLSGNPLSQISALAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE---LLVGPSIETLHAANNNISRV-SCSRGQGKKNIYLANNKITMLRDEGCRSRVQYLDLKLNEIDTVN-AASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH--------------------------------------------------------------------------------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEETVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGTERLECERENQARQREIDALKERTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA------------HAELDGTLQQAVGQIELQHATEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLA--EENARLKKLNGEADLALASANATLQELVVREQNLASQ............................................................................................................................................................................................................................................................................................... 485
28 -60.1004fho_A mol:protein length:231 Internalin C2  ali model follow..  26  2..........................................................................................................................................................................................................AEVRAESIAQPTPINVIFPDPALANAVKTATGKSNVTDAVTQADLDGIATLSAFNTGVTTIEGIQYLNNLIGLELKDNQITDLTPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNNQVNDLTPLANLSKLTTLRADDNKISDISPLASLPNLIEVHLKDNQISDVSPLANLSNLFIVTLT.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 231
29 -59.8005d3i_A mol:protein length:568 Toll-like receptor 2  ali model follow..  16  7...............................................................................................................................................................................................................................SCDASGVCDGRSRSFTSIPS---TAAMKSLDLSFNKITYIGHLRACANLQVLILKSSRINTIEGFYSLGSLEHLDLSDNHLSSLSSFGPLSSLKYLNLMGNPYQTLSLFPNLTNLQTLRIGNVETFSEIDFAGLTSLNELEIKALSLRNYQSLKSIRDIHHLTLHLSESAFLLEADILSSVRYLELRDTNLARFQKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES-----------------------------------------------------------------------DVVSELGKVETVTIRRLHIPQFYLFYDLSYSLLEKVKRITVENSKVFLVPCSQHLKSLEFLDLSENLMVEEACKGAWPSLQTLVLSQNHLRSMQKLLTLKNLTSLDISRNTFHPMP-DSCQWPEKMRFLNLSSTGIRVVKT-CIPQTLEVLDVSNNNLDSFS--LFLPRLQELYISRNKLKTLPDASLFPVLLVMKIRENAVSTFSKLGSFPKLETLEAGDNHFV................................................................................................................................................................................................................................................................................................................... 514
30 -59.6004bsr_A mol:protein length:539 LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUP  ali model follow..  19  1....................................................................................................................................................................................................................................ENLYFQGSGSSPRSGEPDGRMLLRVDCSDLGLSELPS-NLSVFTSYLDLSMNNISQLLPLPSLRFLEELRLAGNALTYIPKFTGLYSLKVLMLQNNQLRHVPTLQNLRSLQSLRLDANHISYVPPFSGLHSLRHLWLDDNALTEIPVFRSLSALQAMTLALNKIHHIPDFGNLSSLVVLHLHNNRIHSLGKFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSNNIRSIPE-------------------------------------------------------------------------------KAFVGNPSLITIHFYDNPIQFVGRFQHLPELRTLTLNGASQITEPDLTGTANLESLTLTGAQISSLPQCNQLPNLQVLDLSYNLLEDLPSFSVCQKLQKIDLRHNEIYEIKVDTFQQLLSLRSLNLAWNKIAIIHPFSTLPSLIKLDLSSNLLSSF-PITGLHGLTHLKLTGNHALQSENFPELKVIEMPYAYQCCAFGVCEYKISNQWNKGNSSMDDLHKKD--AGMFQAQDERDLEDFLLDFEE......................................................................................................................................................................................................................................................................................... 518
31 -59.5003rgx_A mol:protein length:768 Protein BRASSINOSTEROID INSENSITIVE 1  ali model follow..  15  51...........................................................................................................................................................................................................KVTSIDLSSKPLNVGFSSLLSLTGLESLFLSNSHINGVSGFKCSASLTSLDLSRNSLSGLTSLGSCSGLKFLNVSSNTLDFVSGGLKLNSLEVLDLSANSISGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTIPFLGDCSALQHLDISGNKLSG-RAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPSGACDTLTGLDLSGNHFYAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-----------------------------------------------------GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNPKNTLQELYLQNNGFTG-PTLSNCSELVSLHLSFNYLSGTIPLGSLSKLRDLKLWLNMLEGPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG-KWIGRLENLAILKLSNNSFSG-AELGDCRSLIWLDLNTNLFNGYVYIKNDGMKKECHGAGNLLE--EQLNRLSTRNPCNITSRVYGGTSPTFDNNGSMMFLDMSYNMLS----------------------GYIPKEIGSMPYLFILNLGHNDISSIPDEVGDLRGLNILDLSSNKLDRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP........................................................................................................................................................................... 738
32 -59.5004kt1_A mol:protein length:504 Leucine-rich repeat-containing G-protein coup  ali model follow..  16  5.................................................................................................................................................................................................................................................AAPCSCDGDRRVDCSGKGLTAVPE-GLSAFTQALDISMNNITQLPEFKNFPFLEELQLAGNDLSFIHPLSGLKELKVLTLQNNQLKTVPSIRGLSALQSLRLDANHITSVPEFEGLVQLRHLWLDDNSLTEVPVLSNLPTLQALTLALNKISSIPDFTNLSSLVVLHLHNNKIRSLSQFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELGFHSNSISVIPD-------------------------------------------------------------------------------GAFDGNPLLRTIHLYDNPLSFVGNFHNLSDLHSLVIRGASMVQQPNLTGTVHLESLTLTGTKISSIPNCQEQKMLRTLDLSYNNIRDLPSFNGCHALEEISLQRNQIYQIKEGTFQGLISLRILDLSRNLIHEIHSFATLGPITNLDVSFNELTSFPT-EGLNGLNQLKLVGNFKLKEAAAKDFVNLRSLSVPYAYQCCA--FWGCDSYANLNTEDNSLQDHSVQEKGTADAANVTSTLENEEHSQIIIHCTPS................................................................................................................................................................................................................................................................................. 500
33 -59.5004lsa_A mol:protein length:774 Protein BRASSINOSTEROID INSENSITIVE 1  ali model follow..  15  50...........................................................................................................................................................................................................KVTSIDLSSKPLNVGFSSLLSLTGLESLFLSNSHINGVSGFKCSASLTSLDLSRNSLSGLTSLGSCSGLKFLNVSSNTLDFVSGGLKLNSLEVLDLSANSISGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTIPFLGDCSALQHLDISGNKLSGSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPSGACDTLTGLDLSGNHFYAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-----------------------------------------------------GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNPKNTLQELYLQNNGFTG-PTLSNCSELVSLHLSFNYLSGTIPLGSLSKLRDLKLWLNMLEGPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG-KWIGRLENLAILKLSNNSFSG-AELGDCRSLIWLDLNTNLFNGYVYIKNDGMKKECHGAGNLLE--EQLNRLSTRNPCNITSRVYEGTSPTFDNNGSMMFLDMSYNMLS----------------------GYIPKEIGSMPYLFILNLGHNDISSIPDEVGDLRGLNILDLSSNKLDRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP........................................................................................................................................................................... 737
34 -59.5004r5c_A mol:protein length:304 Leucine rich repeat protein  ali model follow..  26  3......................................................................................................................................................................................................................................................................................................................................................TVSTPIKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQGV----------------------------------------------------------------------------------------------------------------------------FEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQGVFERLTSLHTLDLSNNGITDISALKNLDNLHTLDLSNNGITDISALKNLDNLHTLDLSNNGITDISALKNLTSLHTLDLSNNGITDISALKNLDNLETLDLRNNGI.................................................................................................................................................................................................................................................................................................................... 304
35 -58.9004aw4_A mol:protein length:311 INTERNALIN B  ali model follow..  20  2...........................................................................................................................................................................................................................................................................................................................AMETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNLTSLNLSNNQITDISPIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL--------------------------------------------------------------------------------------------------------SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE..................................................................................................................................................................................................................................................................................................................................................... 311
36 -58.2003oja_B mol:protein length:597 Anopheles Plasmodium-responsive Leucine-rich  ali model follow..  13  2........................................................................................................GGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFETLNNQKIVTFKNSTMRKLPA--------------------------------------------------ALLDSFRQVELLNLNDLQIEEIDTFAYAHTIQKLYMGFNAIRYLPPFQNVPLLTVLVLERNDLSSLPRFHNTPKLTTLSMSNNNLERIEDFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLST---LAIPIAVEELDASHNSINVVRG-PVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLHVE--------------------------------------------------------------------------------RNQPQFDRLENLYLDHNSIVTL-KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDCCKESDKPYLDRQYIALTSVVEQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEQQLTNEQIQQEQLLQGLHAEIDTLRRYRLPKDGLARSSDNLNKVTHLKERQAFKLRETQARRTEADAKQKETEDLKQLDNKRAKQAELRQESLKRQKVKQLEAKKNRNPDTRRVS...................................................................................................................................................................................................................................................................................... 591
37 -58.1004ow2_A mol:protein length:448 Yop effector YopM  ali model follow..  16  2..................................................................................................................................................................................................................SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD---DRQAHELELNNLGLSSLPEL--PPHLERLVASCNSLTELPEL--PQSLKSLEVYENNLKALPDL--PPLLVDLRVFNNQLEELPELQNLPFLTEIYANNNSLKTLPDL--PPSLVDLNVRENYLTALPEL--PQSLIFLDISDNILSGLSEL---PNLSCLDASRNGIRSLCDL--PPSLVYLDVRDNQLIELPALPS---GLERLIASFNHLAEL--------------------------------------------------------------------------------PELPPNLYYLDASRNEISSLCDLPP-----SLVDLNVRKNQLIELPAL--PPDLERLIASFNHLAELPEL--PPNLSYLDASRNEISSLCDL--PPSLVDLNVRKNQLIELP----ALPPDLERLIASFNHLAELPEL--PPNLSYLDASRNEISSLCDL--PPSLVELDVRDNQLIELPAL--PPHLERLIASLNHLAEVPEL--PQNLKQLHVEHNALREFPDIPESVEDLRM..................................................................................................................................................................................................................................................................................................... 447
38 -57.7003j0a_A mol:protein length:844 Toll-like receptor 5  ali model follow..  14  4.................................................................................................................................................................................................................................FDGRIAFYRFCNLTQVP--QVLNTTERLLLSFNYIRTVSSFPFLEQLQLLELGSQYTPDKEAFRNLPNLRILDLGSSKIYFLHPFQGLFHLFELRLYFCGLSDAVYFRNLKALTRLDLSKNQIRSLYLFGKLNSLKSIDFSSNQIFLVCE--QGKTLSFFSLAANSLYSRVSVDRNMVLEILDVSGNGWTQAFSLILAHHIMGAGFGFHNIKDPDQNT-ARSSVRHLDLSHGFVFSLNSFETLKDLKVLNLAYNKINK---------------------------------------------------------IADEAFYGLDNLQVLNLSYNLLGELYSFYGLPKVAYIDLQKNHIAIIQDFKFLEKLQTLDLRDNALTT---IHFIPSIPDIFLSGNKLVTLP--KINLTANLIHLSENRLENLILYFLLRVPHLQILILNQNRFSSCSGPSENPSLEQLFLGENMLQLADVFEGLSHLQVLYLNHNYLNSLPPFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFI............................................................................................................................................................................................................................................................................................ 560
39 -57.0004cil_A mol:protein length:287 YOPM-CAP, INTERNALIN B  ali model follow..  19  2.....................................................................................................................................................................................................................................................................................................................................................AMGKSKAEYYNAWSEWERNAPPGNGEQRGMAVSRLRDCLQAHELELNNLGLSSLPGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL--------------------------------------------------------------------------------------------------------SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE..................................................................................................................................................................................................................................................................................................................................................... 287
40 -57.0004j0m_A mol:protein length:740 Serine/threonine-protein kinase BRI1-like 1  ali model follow..  13  54....................................................................................RIVGLDLRNSGLTGTLNNLTALPNLQNLYLQGNYFSSGGDSSGSDCYLQVLDLSSNSISD-YVFSKCSNLVSVNISNNKLVG---------------------------KLGFAPSSLQSLTTVDLSYNILSDKIPE-DFPASLKYLDLTHNNLSGDFSFGICGNLTFFSLSQNNLSG-ITLPNCKFLETLNISRNNLAG-EYWGSFQNLKQLSLAHNRLSGPPELSLLKTLVILDLSGNTFSGELPFTACVWLQNLNLGNNYLSG-TVVSKITGITYLYVAYNNISGPISLTNCSNLRVLDLSSNGFTGFCSLQSSPVLEKILIANNYLSGTVPLGKCKSLKTIDLSFNELTPIPKEIWMLPNLSDLVMWANNLTGTIPEGKGGNLETLILNNNLLTGSIP---------------------------------------------------------ESISRCTNMIWISLSSNRLTG-SGIGNLSKLAILQLGNNSLSG-RQLGNCKSLIWLDLNSNNLTGDLPLASQAGLVMPGSVSGKQFAFVR-NEGGTDCRGAGGLVEFEGIRAERLERL-PMVHSCPATRIYSGMYTFSANGSMIYFDISYNAVSG-PGYGNMGYLQVLNLGHNRITG-DSFGGLKAIGVLDLSHNNLQGYLPLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNS.............................................................................................................................................................................................................................................................................................. 721
41 -57.0001otm_A mol:protein length:236 internalin B  ali model follow..  29  2....................................................................................................................................................................................................................GSSSSGLVPRGSHMASETITV-STPIKQIFPDAAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKP...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 228
42 -56.9004r58_A mol:protein length:220 Leucine Rich Repeat protein  ali model follow..  30  1..............................................................................................................................................................................................................ETITVSTP-IKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNLKTLKLSNNKITDISALKQLNNLGWLDLSNNGITDISALKNLASLHTLDLSNNGITDISALKNLDNLHTLDLSNNGITDISALKNLDNLHTLDLSNNGITDISALKNLTSLHTLDLSNNGITDISALKNLDNLETLDLRNNGITDKSALKNLNNLK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 220
43 -56.9004kng_A mol:protein length:531 Leucine-rich repeat-containing G-protein coup  ali model follow..  19  12...................................................................................................................................................................................................................................................EPDGRMLLRVDCSDLGLSELPS-NLSVFTSYLDLSMNNISQLLPLPSLRFLEELRLAGNALTYIPKFTGLYSLKVLMLQNNQLRHVPTLQNLRSLQSLRLDANHISYVPPFSGLHSLRHLWLDDNALTEIPVFRSLSALQAMTLALNKIHHIPDFGNLSSLVVLHLHNNRIHSLGKFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSNNIRSIPE-------------------------------------------------------------------------------KAFVGNPSLITIHFYDNPIQFVGRFQHLPELRTLTLNGASQITEPDLTGTANLESLTLTGAQISSLPQCNQLPNLQVLDLSYNLLEDLPSFSVCQKLQKIDLRHNEIYEIKVDTFQQLLSLRSLNLAWNKIAIIHPFSTLPSLIKLDLSSNLLSSF-PITGLHGLTHLKLTGNHALQSLNFPELKVIEMPYAYQCCAFGVCEYKISNQWNKGD-NSSMDDLHKKDAGMFQAQDERDLEDFLLDFEE......................................................................................................................................................................................................................................................................................... 502
44 -56.7004li1_B mol:protein length:432 Leucine-rich repeat-containing G-protein coup  ali model follow..  18  10.................................................................................................................................................................................................................................................PAPCACDLDGGADCSGKGLVTVPD-GLSVFTHSLDLSMNNITKLPEFKGFPYLEELRLAGNDLSIIHPLSGLKELKVLTLQNNQLKTVPSLKGLVSLQSLRLDANHIVTVPEFEGLVQLRHLWLDDNSLTEVPILSNLPSLQALTLALNKISHIPDFSNLSSLVVLHLHNNKIRTLGPFHGLDNLEALDLNYNNLIDFPDSIRSLPNLKELGFHSNSITIIPD-------------------------------------------------------------------------------GAFVKNPLLRTIHLYDNPLSFVGNFQNLSDLHFLIIRGASNVQWFPLTGTNNLESLTLTGTKIRSIPICQEQKMLRTLDLSYNEISALVGFEGCSSLEEVYLQNNQIQEVQNETFQGLAALRMLDLSRNRIHTIHKFVTLKALTNLDLSFNDLTAFPT-AGLHGLNQLKLTGNPNFKET............................................................................................................................................................................................................................................................................................................................................................ 430
45 -56.2004ufr_A mol:protein length:484 LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUP  ali model follow..  19  13...................................................................................................................................................................................................................................................EPDGRMLLRVDCSDLGLSELPS-NLSVFTSYLDLSMNNISQLLPLPSLRFLEELRLAGNALTYIPKFTGLYSLKVLMLQNNQLRHVPTLQNLRSLQSLRLDANHISYVPPFSGLHSLRHLWLDDNALTEIPVFRSLSALQAMTLALNKIHHIPDFGNLSSLVVLHLHNNRIHSLGKFDGLHSLETLDLNYNNLDEFPTAIRTLSNLKELGFHSNNIRSIPE-------------------------------------------------------------------------------KAFVGNPSLITIHFYDNPIQFVGRFQHLPELRTLTLNGASQITEPDLTGTANLESLTLTGAQISSLPQCNQLPNLQVLDLSYNLLEDLPSFSVCQKLQKIDLRHNEIYEIKVDTFQQLLSLRSLNLAWNKIAIIHPFSTLPSLIKLDLSSNLLSSF-PITGLHGLTHLKLTGNHALQSLSSENFPELKVIEMPYAYQCCAFGVCEGNNGDSVQCSPS...................................................................................................................................................................................................................................................................................................................... 472
46 -55.3004eco_A mol:protein length:636 Uncharacterized protein  ali model follow..  12  1.................GGEQFTVKDNALTDDAI---------------------------VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM------GAQPGVSLNSNGRVTGLSLEGFGASG-DAIGQLTELEVLALGSHGEKVNERLKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKSSRITLKDTQIGQLSNNITFVSKVMRLTKLRQFYMGNSPFVA-ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNPNLTKLPFLKALPEMQLINVACNRGISGEQLK------------DDWQALADAPVGEKIQIIYIGYNNLKTFPSLQKMKKLGMLECLYNQLEGKPAFGSEIKLASLNLAYNQITEIPACGFTEQVENLSFAHNKLKYIPNDAKSVSVMSAIDFSYNEIGSVDGKNFDP-------------------------------------------------------------------------DPTPFKGINVSSINLSNNQISKFPKFSTGSPLSSINLMGNMLTEIPKFKNTYLLTSIDLRFNKLTKLSDATTLPYLVGIDLSYNSFSKFPTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNE-KITPNISVLDIKDNPNISISYVCPYIEAGMYMLFYDKTQDIR------GCDALDIKR............................................................................................................................................................................................................................................................................................................................................. 636
47 -54.6002y5q_A mol:protein length:362 INTERNALIN B  ali model follow..  17  5..................................................................................................................................................................................................................................................................................................................................................SETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL--------------------------------------------------------------------------------------------------------SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFK................................................................................................................................................................................................................................................................................................................ 328
48 -54.0001h6u_A mol:protein length:308 INTERNALIN H  ali model follow..  18  2........................................................................................................................................................................................................................................................................................................SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNI--------------------------------------------------------------------------------------------------------SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTVTQPLTE........................................................................................................................................................................................................................................................................................................................................................................... 308
49 -53.8002wqw_A mol:protein length:286 INTERNALIN B  ali model follow..  19  1...................................................................................................................................................................................................................................................................................................................................................ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL--------------------------------------------------------------------------------------------------------SSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLACLTKLQNLYLSKNHISDLRALCGLKNLDVLELFSQEALNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE..................................................................................................................................................................................................................................................................................................................................................... 286
50 -53.5002wqx_A mol:protein length:289 INTERNALIN B  ali model follow..  25  1..................................................................................................................................................................................................................................GAMETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIRRIVPLARLTKLQNLYLSKNHISDLRALRGLKNLDVLELFSQEALNKPNHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 259
51 -53.5004z5w_A mol:protein length:642 Phytosulfokine receptor 1  ali model follow..  16  49............................................................................................................................................................................................KSSVSLGLDDVNESGRVVELELGRRKLSGKLSSVAKLDQLKVLNLTHNSLSG-ASLLNLSNLEVLDLSSNDFSGFPSLINLPSLRVLNVYENSFHGLIPCNNLPRIREIDLAMNYFDGPVGIGNCSSVEYLGLASNNLSGSIPLFQLSNLSVLALQNNRLSG-SKLGKLSNLGRLDISSNKFSGPDVFLELNKLWYFSAQSNLFNGPRSLSNSRSISLLSLRNNTLSGQIYCSAMTNLTSLDLASNSFSSIPSNLPNCLRLKTINFAKIKFIAQIP-------------------------------------------------------------------------------ESFKNFQSLTSLSFSNSSIQNISSLQHCQNLKTLVLTLNFQKEELP-LQFKNLKVLIIASCQLRGTVPLSNSPSLQLLDLSWNQLSG-PWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVSKENAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFPPM--------IDLSYNSLNG-PEFGDLRQLHVLNLKNNNLSGNIPLSGMTSLEVLDLSHNNLSGIPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGN........................................................................................................................................................................................................................................................................ 615
52 -53.0004l3f_A mol:protein length:347 Internalin K  ali model follow..  14  3.........................................................................................................................................................................................................................................................................................................................................SSSSGLVPRGSHMAASQDNVNI-PDSTFKAYLNGLLGQASTANITE-AQMDSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNQISGLSNLERLRIMGADVTSDKPNLSGLTNLTLLDLSHSAHDD-------------------------------------------------------------------------------SILTKINTLPKVTSIDLSYNGITDIMPLKTMPELKSLNIQFDGVHDYRGIEDFPKLNTLLAYSQTIGGKKLINSDIKSSKLTYNAENQTLYVPFSLMTERTVNYDGYVPD-------FVKSTASSDTYFTMNEQQ-VNGNRLTITSDGLTVSDVSKTDFDNLEKMEYNARIDLSYQSYNTPEQFQNGGSYTISMPIYDHYFTVDHSLNITADSE............................................................................................................................................................................................................................................................................................................................ 340
53 -51.9004mna_A mol:protein length:662 LRR receptor-like serine/threonine-protein ki  ali model follow..  18  49...........................................................................................................................................................................................................HVVSVSLLEKQLEGVLSPIANLTYLQVLDLTSNSFTG-AEIGKLTELQSLVLTENLLEG-AEIGNCSSLVQLELYDNQLTGPAELGNLVQLQALRIYKNKLTSPSSLFRLTQLTHLGLSENHLVGPISIGFLESLEVLTLHSNNFTG-QSITNLRNLTVLTVGFNNISGPADLGLLTNLRNLSAHDNLLTGPSSISNCTGLKLLDLSHNQMTGEIPRGGRMNLTFISIGRNHFTEIPDDIFNCSNLETLSVADNNLTGTLKIGKLQKLRILQVSYNSLTGPIP--------------------------------REIGNLKDLNILYLHSNGFTGRI-PREMSNLTLLQGLRMYSNDLEG-EEMFDMKLLSVLDLSNNKFSG-ALFSKLESLTYLSLQGNKFNGSIPLKSLSLLNTFDISDNLLTGTIPGELLASLKNLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSG-RSLQACKNVFTLDFSQNNLSGHIPDE-MDMIISLNLSRNSFSG-QSFGNMTHLVSLDLSSNNLTGEIPLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNT.............................................................................................................................................................................................................................................................................................. 636
54 -51.9004qxe_A mol:protein length:443 Leucine-rich repeat-containing G-protein coup  ali model follow..  17  10.....................................................................................................................................................................................................................................................SCDGDRRVDCSGKGLTAVPE----AFTQALDISMNNITQLPEFKNFPFLEELQLAGNDLSFIHPLSGLKELKVLTLQNNQLKTVPSIRGLSALQSLRLDANHITSVPEFEGLVQLRHLWLDDNSLTEVPVLSNLPTLQALTLALNKISSIPDFTNLSSLVVLHLHNNKIRSLSQFDGLDNLETLDLNYNNLGEFPQAIKALPSLKELGFHSNSISVIPD-------------------------------------------------------------------------------GAFDGNPLLRTIHLYDNPLSFVGNFHNLSDLHSLVIRGASMVQQFPLTGTVHLESLTLTGTKISSIPNCQEQKMLRTLDLSYNNIRDLPSFNGCHALEEISLQRNQIYQIKEGTFQGLISLRILDLASNQLKSVPDFDRLTSLQKIWLHTNPWDSCPRIDYLSRW--LNKNSQKEQGSAKSGSGKPVRSIICPT............................................................................................................................................................................................................................................................................................................................................. 442
55 -51.5004r5d_A mol:protein length:441 Leucine rich repeat protein  ali model follow..  18  1....................................................................................................................................................................................................................................ATITVSTPIKQIFPD-DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQFEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTSLTTLNLSNNQLTSLPDGVERLTNLKTLNLSNNQLTKEACRAV---------------------------------------------------------------------------ANALKQAASLHELHLSNNNIGEEG-LHPGSTLETLDLSNCNLTKERALKQATTLHELHLSNNNIGEEG-LHPGSTLETLDLSNCNLTKERALKQATTLHELHLSNNNIGEEGAAELHPGSTLETLDLSNCNLTKERALKQATSLHELHLSNNNIG..................................................................................................................................................................................................................................................................................................................................................................................... 441
56 -51.5004u09_A mol:protein length:401 LIC12759  ali model follow..  20  2................................................................................................................................................................................................................EEIQKPYKNLAKALQNPADVRNLDLSFQGLKTLPNIGQLKNLQKLDLGGNEPTILSEIWQLKDLQKLNLNNNKLTVLPEIGQLQNLQELSLHSNELVNLPEIGQFKNLQKLNLDNNKLTVLKEIGQLQNLQELSLLSNKLISLTEIEQLKSLKNLDLNHNEFTTVSEVMLLETLENLDLRSNKLKTIKEIRQLKSLKVLMLTGNQLTSLKEIEQLQNLKTLNLGENRFQIFPVEILELKNLLELNLYYNQLVEF--------------------------------------------------------------------------------PKEVGQLKSLKYLSLYHNQITTLVEVTQLPDLQELHLSGNKITILPEILQLKNLEWLSLSNNKLNALKEIGQLKKLQRLELGNNQLTTLPEIEQLKNLQRLELDSNPISPKEKERIRKLLPKCEIDFEGGGGE........................................................................................................................................................................................................................................................................................................................................................................................................... 401
57 -51.2004z63_A mol:protein length:631 Phytosulfokine receptor 1  ali model follow..  17  54...........................................................................................................................................................................................................RVIRLELGNKKLSGKLSELGKLDEIRVLNLSRNFIKD-LSIFNLKNLQTLDLSSNDLSGIPTSINLPALQSFDLSSNKFNGSLP-HNSTQIRVVKLAVNYFAGTSGFGKCVLLEHLCLGMNDLTGNIPLFHLKRLNLLGIQENRLSGSREIRNLSSLVRLDVSWNLFSGPDVFDELPQLKFFLGQTNGFIGPKSLANSPSLNLLNLRNNSLSGRLMCTAMIALNSLDLGTNRFNRLPENLPDCKRLKNVNLARNTFHGQVP-------------------------------------------------------------------------------ESFKNFESLSYFSLSNSSLANISSLQHCKNLTTLVLTLNFHGEALP-LHFEKLKVLVVANCRLTGSMPLSSSNELQLLDLSWNRLTG-SWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPMKRNESARALQTIELGHNNLSG-EEFGNLKKLHVFDLKWNALSG-SSLSGMTSLEALDLSNNRLSGSIPLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHL............................................................................................................................................................................................................................................................................................. 607
58 -49.6004cc4_A mol:protein length:266 INLC PROTEIN  ali model follow..  16  7...................................................................................................................................................................................................................RPTPINQVFPDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNLNGIPSA-CLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNLYITNTVKDPDGRWISPAAISNGGSYVDGCVLWELPVYTDEVSYKFS-EYINVGETEAIFDGTVTQPIKN.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 265
59 -48.7004r6j_A mol:protein length:254 Lucine rich repeats DLRR_H  ali model follow..  18  1.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TITVSTPIKQIFPD-DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQGVFEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNNLANLNDFEGLTNLTTLNLSNNNLARLWKLKGLTNLTTLNLSNNGFDEFPKFKDLTSLTTLNLSNNQLTSLPQGVERLTNLKTLNLSNNQLQSLPT........................................................................................................................................................................................................................................................................................ 253
60 -48.3004u08_A mol:protein length:398 LIC11098  ali model follow..  21  1..............................................................................................................................................................................................................QSNEAQTYYRNITEALKNPQNVRILNLSGSKLTTLPEIGKLQNLQLLNLDDNQLIALPKIGKLQNLQQLHLSKNQLMALPEIGQLQNLQKLKLYENQLTAIPEIGQLQNLQELNLAHNQLATLPEIEQLQRLQTLYLGHNQFNSIKEIGQLQNLESLGLDHNQLNVLPEIGQLRNLESLGLDHNQLNVLKEIGQLQNLQILHLRNNQLTTLKEIGQLQNLQKLLLNKNKLTTLPKEIGQLQNLQKLKLYENQLTTL--------------------------------------------------------------------------------PKEIGQLQNLQELDLDGNQLTTLENIGQLQRLQTLYLGNNQLNFLPKIGQLRNLESLDLEHNQLNALPKIGKLQKLQTLNLKYNQLATLPEIKQLKNLKKLYLHNNPLPSEKIARIRKLLPQCIIYFEE............................................................................................................................................................................................................................................................................................................................................................................................................... 398
61 -48.2004u7l_A mol:protein length:456 Leucine-rich repeats and immunoglobulin-like  ali model follow..  19  9....................................................................................................................................................................................................................................................................................................SGDSLDCGGRGLAALPG-DLPSSTRSLNLSYNKLSEIDPFEDLPNLQEVYLNNNELTAVPSGAASSHVVSLFLQHNKIRSVEGLKAYLSLEVLDLSLNNITEVRNFPHGPPIKELNLAGNRIGTLEL-GLSRSLLTLRLSKNRITQLPVRAFKLPRLTQLDLNRNRIRLIEG-------------------------------------------------------------------------------LTFQGLNSLEVLKLQRNNISKLTDFWGLSKMHVLHLEYNSLVEVNSLYGLTALHQLHLSNNSIARIHRWSFCQKLHELVLSFNNLTRLDELAELSSLSVLRLSHNSISHIAEGAFKGLRSLRVLDLDHNEISGTIEFSGLDSLSKLTLFGNKIKSVAKFSGLEGLEHLNLGGNAIRSVQFFVKMKNLKELHISSDSFLCDCQLKWLPPWLI--------GRMLQAFVTATCAHPESLKGQSIFSVPPESFVCDDFLK.............................................................................................................................................................................................................................................................................. 455
62 -48.0001m9s_A mol:protein length:605 Internalin B  ali model follow..  16  1...................................................................................................................................................................................................................................MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPNHQSNLVVPNTVKNTDGSLVTP---------------------------------------------------------------------------------EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKAETTEKTVNLTRYVKYIRGNAGIYKLPREDNSLKQGTLASHRCKALTVDREARNGKLWYRLKNIGWTKAENLSLDRYDKMEYDKGVTAYARVNASGNSVWTKPYNTAGAKHVNKLSVYQGKNMRI.......................................................................................................................................................................................................................................................................................... 483
63 -47.8004r6f_A mol:protein length:331 Leucine rich repeat DLRR_I  ali model follow..  19  11...................................................................................................................................................................................................................................................................................................................QIFPDDAFAETIKANLKKKSVTDAQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQFEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNNIANINDQLEGLTNLTTLNLSHNNLARLWK-----------------------------------------------------------------------HANPGGPIYFLKGLTNLTTLNLSSNGFDEIPRFKDLTSLTTLNLSNNNIANINDLEGLTNLTTLNLSHNNLARLWKLKGLTNLTTLNLSSNGFDEIPRFKDLTSLTTLNLSNNQLTSLPQGVFERLTNLKTLNLSNNQLQS.......................................................................................................................................................................................................................................................................................................................................................................................................... 331
64 -46.8004l3a_A mol:protein length:590 Internalin K  ali model follow..  12  2.........................................................................................................................................................................................................................................................................................GSSSSGLVPRGSHMASMTGGQQMGRDPVFAAEQPGLKASQDNVNIPD----STFKAYLNGLLGQASTANITE-AQMDSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNQISGLSNLERLRIMGADVTSIPNLSGLTNLTLLDLSHSAHDD------------------------------------------------------------------------------------------------------SILTKINTLPKVTSIDLSYNGITDIMPLKTMPELKSLNIQFDGVHDYRGIEDFPKLNTLLAYSQTIGGKKLINSDIKSSKLTYNAENQTLYVPFSLMTERTVNYDGYVPDFVKSTASSDTYFTMNEQQVNGNRLTITS--------DGLTVSDVSKTDFDNLEKMEYNARIDLSYQSYNTPEQFQNGGSYTISMPIYDHYFTVDHSLNITADSEKTYIENQLVTEATFLSDI--------------------------------------------HAKTDDGSTVTSDFADKVDFNTPGTYTVTLQSENNAGLKATPVQVNVTIKAKTTITADEKITYKVDTSKTEAAFLA----------------------DIKATTNDGTAITSDFATVVDLSKPGKYVVTLNAENDLQ--------KALPVQVMVIVEKETPIPDPTPTPTPDPTPTPDPSPTPNPVINPNVNKPEVPSYKIPSLTVNEKKAKAEPKEAVDKLAAA............................. 576
65 -46.8004psj_A mol:protein length:271 OR464  ali model follow..  19  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MGTITVSTPIKQIFPD-DAFAETIKANLKKKSVTDAVTQNELNSIDQINANNSDIKSVQGIQYLPNVRQLNLGGNKLHDISALKELTNLGWLNLSSNKIEKLPQGLFESLTTLTQLNLSNNQITSLPQFESLASLTQLNLSNNQITSLPQFESLTNLTQLNLSNNQITSLPQFESLTNLTQLNLSNNQITSLPQFESLTSLTQLNLSNNQITSLPQGLESLTNLKQLNLSGNQIQSLPQGLHESLTQLTGS............................................................................................................................................................................................................................................................................ 259
66 -46.7003bz5_A mol:protein length:457 Internalin-J  ali model follow..  15  1.............................................................................................................................................................................................................NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTIS-EEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTLD-LSQNTNLTYLACDSNKLTNLD-VTPLTKLTYLNCDTNKLTKLD-VSQNPLLTYLNCARNTLTEID-VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELD-VSQNKLLNRLNCDTNNITKLD-LNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPLTEL----------------------------------------------------------------------------------DVSTLSKLTTLHCIQTDLLEID-LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELD-LSQNPKLVYLYLNNTELTELD-VSHNTKLKSLSCVNAHIQDFSSVGNNFEAEGQTITMPKETLTNNS-LTIAVSPDLLDQFGNPMNIEP-----GDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGT...................................................................................................................................................................................................................................................................................................................................... 445
67 -46.3004pq8_A mol:protein length:271 DESIGNED PROTEIN OR465  ali model follow..  17  1............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MGTITVSTPIPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDISALKELTNLGWLNLSNNQLETLPQGVFEKLTNLTTLNLSNNQLTSLPQFERLASLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTNLTTLNLSNNQLTSLPQFERLTSLTTLNLSNNQLTSLPQGVERLTNLKTLNLSNNQLQSLPTGVDEKLTQLTGS............................................................................................................................................................................................................................................................................ 259
68 -46.1004xgo_A mol:protein length:356 Anopheles Plasmodium-responsive Leucine-rich  ali model follow..  16  2.........................................................................................................................................................................................................................................................................................................................................................................QLSYKSMHLTPFALLASFHKVEVLNLNGLQIEEIDTFAYAHTIQKLYMRFNVIRYLPPFQNVPLLTVLMLDRNDLSSLPPGFHNTPKLTMMSMSNNNLERIED-------------------------------------------------------------------------------DTFQATTALQNLQLSSNRLTHV-DLALIPSLFHVNVSYNLLST---LAIPIAVEELDASHNTINVVRG-PVNVELTILKLQHNNLTDTAWLLNYPGLVDVDLSYNQLEKITYQHFVKMQRLERLYVSNNRLVALDFGRPIPTLKVLDLSHNHLMWVEHQAQFDKLQYLYLDHNSIVTFK-LSTSHTLKNLTLSHNDWDCNSLRALFRNVAQPAVHDADQHKIDYHLEHGLCCKESDKPYLD.............................................................................................................................................................................................................................................................................................. 350
69 -46.0003v47_A mol:protein length:455 Toll-like receptor 5b and variable lymphocyte  ali model follow..  14  13......................................................................................................................................................................................................................................................................................................YNAICINRGLHQVPEL---AHVNYVDLSLNSIAELNEFSRLQDLQFLKVEQQTPGLVNTFRGLSSLIILKLDYNQFLQLETFNGLANLEVLTLTQCNLDGANFFKPLTSLEMLVLRDNNIKKIQPFLNMRRFHVLDLTFNKVKSICEED-QGKHFTLLRLSSITLQDMN-----------------------------------------------------------------------EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAFFDAIAGTKIQSLILSNS---------YNMGSSFGHTNFKDPDN--EASGVKTCDLSKSKIFALLKFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSFENLDKLEVLDLSYNHIRALGDFLGLPNLKELALDTNQLKSVPDFDRLTSLQKIWLHTNPWD......................................................................................................................................................................................................................................................................................................................................... 408
70 -45.9004q62_A mol:protein length:422 Leucine-rich repeat-and coiled coil-containin  ali model follow..  12  1..........................................................................................................................................................................................................................................SNAIKQHQVKLVLKTSQDIQLFLNALRD-SRNHGISSLSELDLSDTRFTNVTALNNIPGIKSLRLDSCGLKDTVELSKLTHIKKLSLKSNYLKNRP---FNSMLEALYLDYNTELSASYSRNAAALKKLSLRNCGVTD-RPESRLKSLTHFNLRRNNITHVDSFAHLQSLTTIDLSQNTGEGVSRLAPLKQLRTLYLDNCGIGGEGIKAIAKMNLQTVDLSFNPGL-----------------------------------------------------------------------------KKEWGLDDIRPNHTIRTLLLTFCSLND---VSKFPAATDLNVANNNMTRVKTLLSNPIIENLDVSTQSLYATGMISPRIMMKKKEIKQQEKDLLDTICNTITLKSINLEHTGITSRMLLSLIPDETDHKRYLKKINGVSCKELKP.................................................................................................................................................................................................................................................................................................................................................................................................... 408
71 -45.8004ezg_A mol:protein length:197 Putative uncharacterized protein  ali model follow..  16  1.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GAAEQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITE-AQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDLTKINTLPKVNSIDLSYNGITDIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGGKK...................................................................................................................................................................................................................................................................................................................................... 197
72 -45.5001g9u_A mol:protein length:454 OUTER PROTEIN YOPM  ali model follow..  13  1.............................................................................................................................................................................................................................................MFINPRNVSNTFLQEPLRHSSNLTEMPEAENVKSKTEYYNAWSEWERPPGNGEQREMAVSRLRDCLDR---------QAHELELNNLGLSSLPEL--PPHLESLVASCNSLTELPEL--PQSLKSLLVDNNNLKALSDL---PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQLEELPE-LQNLPFLTAIYADNNSLKKLPDL-----------------------------------------------------------------------------------PLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL--PPSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSGLSEL---PNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLIELPAL--PPRLERLIASFNHLAEVPEL--PQNLKQLHVEYNPLREFPDI--PESVEDLRMN-SHLAEVPEL--PQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVF............................................................................................................................................................................................................................................................................. 447
73 -44.8003o53_A mol:protein length:317 Protein LRIM1  ali model follow..  20  4...............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EIKQNGNRYKIEKVTDSSLKQALARQSAWNVKELDLSGNPLSQISALAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQE---LLVGPSIETLHAANNNISRVSCSRG---QGKKNIYLANNKITMLRDEGCRSRVQYLDLKLNEIDTVN-AASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA................................................................................................................................................................................................................................................. 293
74 -43.9005iyx_A mol:protein length:658 Receptor-like protein kinase 5  ali model follow..  17  52..................................................................................................................................................................................................................................NVVSVDLSSFMLVG-SILCHLPSLHSLSLYNNSINGADDFDTCHNLISLDLSENLLVGSIPKSNLPNLKFLEISGNNLSDPSSFGEFRKLESLNLAGNFLSGTIPLGNVTTLKELKLAYNLFSP-SQLGNLTELQVLWLAGCNLVGPPSLSRLTSLVNLDLTFNQLTGPSWITQLKTVEQIELFNNSFSGELPMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLNLFENMLEGPLP-------------------------------------------------------------------------------ESITRSKTLSELKLFNNRLTGVLPLGANSPLQYVDLSYNRFSG-ANVCGEGKLEYLILIDNSFSGEISLGKCKSLTRVRLSNNKLSG-HGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSG-NEIGSLNGIIEISGAENDFSG-ESLVKLKQLSRLDLSKNQLSGPRELRGWKNLNELNLANNHLSGEIPVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLY..................................................................................................................................................................................................................................................................................... 576
75 -42.4004qdh_A mol:protein length:438 Variable lymphocyte receptor B, Toll-like rec  ali model follow..  17  15................................................................................................................................................................................................................................................................................................................................................SGTEIRCNSKGLTSVPT----SSATRLELESNKLQSLPHFDKLTQLTKLSLSRNNLVTIKPFVNLSRLQCLSLSHNSIAQAVNFLPLTNLQVLDLSHNKLDLYHWKFSELPQLQALDLSYNSQPFSMK-------------------------------------------------------------------------GIGHNFSFVTHLSMLQSLSLAHNDIHTRVSHLNSNSVRFLDFSGNGMGRMWDFQGLSGLLKLDLSQNNLHILRP-NLPKSLKLLSLRDNYLSFFNWLSFLPNLEVLDLAGNQLKALTNGTLPNGTLLQKLDVSSNSIVSVVPFALAVELKEVNLSHNILKTVDR-PIVMNLKELALDTNQLKSVPDFDRLTSLQKIWLHTNPWDSCPRIDYLSRW--LNKNSQKEQGSAKCSGSGKPVRSIICPTASLV............................................................................................................................................................................................................................................................................................ 418

FFAS is supported by the NIH grant R01-GM087218-01
1 2 0 2 1 0   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Li W, Godzik A. cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006 May 26;